Related Experiment Video
Updated: Jul 6, 2026
12:24
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Hepatology: a personal story
1Institute of Hepatology, University College London. roger.williams@ucl.ac.uk
Clinical Medicine (London, England)
|March 14, 2008
Summary
Hepatology has advanced significantly since 1959, driven by discoveries in viral hepatitis, immunology, and liver transplantation. Despite progress, rising rates of alcohol-related and non-alcoholic fatty liver disease pose ongoing challenges.
Area of Science:
- Hepatology and Gastroenterology
- Virology
- Immunology
Background:
- Early hepatology (pre-1960s) faced limited diagnostic and therapeutic options for liver diseases.
- The discovery of hepatitis B virus (HBV) in 1967 and hepatitis C virus (HCV) in 1989 marked pivotal moments for the field.
- Advances in understanding immune responses have been crucial for treating autoimmune liver conditions.
Observation:
- The development of effective antiviral therapies revolutionized hepatitis B and C treatment.
- Liver transplantation has emerged as a highly successful treatment modality.
- Emerging liver support devices show potential for managing acute liver failure.
Findings:
- Significant progress in understanding and treating viral hepatitis (HBV, HCV) through targeted therapies.
- Enhanced management of autoimmune liver diseases due to improved immunological insights.
- Liver transplantation has become a life-saving option for end-stage liver disease.
Implications:
- Continued research into novel liver support technologies is warranted.
- Addressing the increasing prevalence of alcohol-related liver disease (ARLD) and non-alcoholic fatty liver disease (NAFLD) is critical.
- Future hepatology advancements will likely integrate virology, immunology, and device technology for comprehensive liver disease management.
Related Concept Videos
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...